News
The first trial of an AI-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine ...
8h
News Medical on MSNHPV vaccine uptake rises with help from AI chatbotThe first trial of an AI (Artificial Intelligence)-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine uptake and engagement with health professionals.
Investigators conducted a study to explore the determinants of HPV vaccine uptake among young women in the U.S. to help produce more effective interventions strategies.
The Iowa Senate advanced a bill Monday that would remove a minor's ability to consent to receiving an HPV vaccine.
TAP on MSN4d
HPV vaccination important step to fight cervical cancer, says Riadh Daghfous (Interview)The recently introduced vaccination against the human papillomavirus (HPV) is an important step in fighting against cervical ...
2d
Khaleej Times on MSNUAE: HPV vaccine prevents cervical cancer, doctors tell parents as 90% target announcedParents are more likely to vaccinate their children against human papillomavirus (HPV) when the vaccine is presented as a way ...
Researchers are using virus-like particles to develop a safer, cheaper polio vaccine to help eradicate the disease once and for all.
3d
FOX 13 Tampa Bay on MSNExperimental breast cancer vaccine creates unique bond between Moffitt patient, cell therapy technologistAn experimental breast cancer vaccine at Moffitt Cancer Center in Tampa created a unique bond between a patient and a cell ...
It aims to eliminate cervical cancer as a public health problem by 2030, with the following strategy: • Vaccinate 90 per cent of girls with preventive HPV vaccines by age 15; • Screen 70 per ...
The mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most promising sectors within the biotechnology and oncology landscape. mRNA, or messenger RNA, serves as a genetic blueprint ...
In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.
Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results